Contract 36C26223F0041
Horizon Therapeutics USA, Inc. · Department Of Veterans Affairs · August 5, 2024
Horizon Therapeutics USA, Inc. was awarded a federal contract by Department Of Veterans Affairs on August 5, 2024 for $591,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in La Vergne, TN. This is a task or delivery order issued under parent IDIQ 36F79719D0224. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $591,000.
Contract details
- PIID
- 36C26223F0041
- Parent IDIQ
- 36F79719D0224
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- La Vergne, TN
- First action
- August 5, 2024
Description
KRYSTEXXA PEGLOTICASE TO TREAT PATIENTS AT VASDHCS
Modification timeline
-
August 5, 2024Mod P00001 · Supplemental Agreement For Work Within Scope$591.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26223F0041?
Contract 36C26223F0041 is a federal contract awarded to Horizon Therapeutics USA, Inc. by Department Of Veterans Affairs on August 5, 2024 for $591,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 36C26223F0041?
Horizon Therapeutics USA, Inc. won contract 36C26223F0041 from Department Of Veterans Affairs.
How much is contract 36C26223F0041 worth?
Contract 36C26223F0041 has obligated $0 to date but carries a potential ceiling of $591,000 if fully funded and all options are exercised.